- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.10. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 07.10. | NewGenIvf GAAP EPS of -$26.64 misses by $44.82, revenue of $1.92M misses by $18.18M | 2 | Seeking Alpha | ||
| 07.10. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 02.10. | NewGenIvf (NIVF) Stock Soars Over 28% After-Hours: What's Driving the Surge? | 3 | Benzinga.com | ||
| 30.09. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 30.09. | NewGenIvf schließt öffentliches Angebot über 1,25 Mio. US-Dollar ab | 1 | Investing.com Deutsch | ||
| NEWGENIVF GROUP Aktie jetzt für 0€ handeln | |||||
| 30.09. | NewGenIvf closes $1.25M public offering at $0.07/share | 1 | Investing.com | ||
| 30.09. | NewGenIVF Group Limited: NewGen Announces Closing of $1.25 Million Public Offering | 4 | GlobeNewswire (USA) | ||
| 29.09. | NewGenIvf announces pricing of $1.25M public offering of shares and pre-funded warrants | 2 | Seeking Alpha | ||
| 29.09. | NewGenIvf prices $1.25M public offering at $0.07 per share | 1 | Investing.com | ||
| 29.09. | NewGenIVF Group Limited: NewGen Announces Pricing of $1.25 Million Public Offering | 1 | GlobeNewswire (USA) | ||
| 10.09. | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 20.08. | NewGenIvf Group Ltd - F-1, Registration statement for certain foreign private issuers | 3 | SEC Filings | ||
| 17.08. | NewGenIVF Group Limited: NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor | 1 | GlobeNewswire (USA) | ||
| 17.08. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 27.07. | NewGenIVF Group Limited: NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million | 479 | GlobeNewswire (Europe) | BANGKOK, July 27, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has entered... ► Artikel lesen | |
| 27.07. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 23.07. | NewGenIVF Group Limited: NewGen's Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai's Valuation Reaches US$200 Million | 1 | GlobeNewswire (USA) | ||
| 06.07. | NewGenIVF Group Limited: NewGen's Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million | 2 | GlobeNewswire (USA) | ||
| 01.07. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 7,762 | +15,99 % | Stifel hebt Kursziel für Teladoc Health an: Kostensenkungen stärken Margen | ||
| SERNOVA BIOTHERAPEUTICS | 0,075 | +8,12 % | Sernova Biotherapeutics mit EILMELDUNG: Könnte die Aktie nach 33,3 % Plus jetzt komplett durchstarten? - Handeln Sie, bevor es zu spät ist! | ||
| CERENOME | 1,460 | +4,73 % | Cerenome completes enrollment in glioblastoma drug trial | ||
| ATOSSA THERAPEUTICS | 2,120 | 0,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 17,700 | 0,00 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,395 | 0,00 % | Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India | .release-content span.prnews_span{font-size:8pt;font-family:"Arial";color:black}.release-content a.prnews_a{color:blue}.release-content li.prnews_li{font-size:8pt;font-family:"Arial";color:black}.release-content... ► Artikel lesen | |
| QUIDELORTHO | 12,505 | -0,40 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,230 | 0,00 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 5,910 | 0,00 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 4,170 | -2,57 % | Clover Health im Aufwind: Needham startet Coverage mit "Buy" und Kursziel von 6 Dollar | ||
| SENSEONICS | 8,050 | -3,59 % | Senseonics Holdings, Inc.: Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World's First CGM System with No On-body Component | ||
| NANO-X IMAGING | 0,303 | 0,00 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| TEMPEST THERAPEUTICS | 0,534 | 0,00 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| IMUNON | 0,805 | +7,33 % | Imunon, Inc. - S-1, General form for registration of securities |
Das Unternehmen NEWGENIVF GROUP LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -5,83 % bei einem Aktienkurs von 1,130 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEWGENIVF GROUP LIMITED finden Sie auf Wallstreet Online.